BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the US Food and Drug Administration (FDA) has approved ...
They're rolling up their sleeves again, seemingly out of fear of missing AI's defining moment and, presumably, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results